Duan C. Hypoxia-inducible factor 3 biology: complexities and emerging themes. Am J Physiol Cell Physiol 310: C260 -C269, 2016. doi:10.1152/ajpcell.00315.2015.-The hypoxia-inducible factor (HIF) family has three distinct members in most vertebrates. All three HIFs consist of a unique and oxygen-labile ␣-subunit and a common and stable ␤-subunit. While HIF-1 and HIF-2 function as master regulators of the transcriptional response to hypoxia, much less is known about HIF-3. The HIF-3␣ gene gives rise to multiple HIF-3␣ variants due to the utilization of different promoters, different transcription initiation sites, and alternative splicing. These HIF-3␣ variants are expressed in different tissues, at different developmental stages, and are differentially regulated by hypoxia and other factors. Recent studies suggest that different HIF-3␣ variants have different and even opposite functions. There is strong evidence that full-length HIF-3␣ protein functions as an oxygen-regulated transcription activator and that it activates a unique transcriptional program in response to hypoxia. Many HIF-3␣ target genes have been identified. While some short HIF-3␣ variants act as dominant-negative regulators of HIF-1/2␣ actions, other HIF-3␣ variants can inhibit HIF-1/2␣ actions by competing for the common HIF-␤. There are also a number of HIF-3␣ variants yet to be explored. Future studies of these naturally occurring HIF-3␣ variants will provide new and important insights into HIF biology and may lead to the development of new therapeutic strategies.
Structure of HIF-3␣ and Its Variants
Human HIF-3␣ gene and HIF-3␣ variants. The human HIF-3␣ gene is located on chromosome 19q13.2. It spans 43 kb and contains 19 exons (12, 35) . To date, 10 different human HIF-3␣ transcripts have been reported (12, 16, (35) (36) (37) (38) . Human HIF-3␣1 (listed as HIF3A-006 in NCBI and Ensembl database) is considered a full-length protein and contains 667 aa (12) . HIF-3␣1 has a bHLH, PAS-A, PAS-B, PAC domain, and an ODD/N-TAD domain (Fig. 1A) . These domains share high sequence identity with those of human HIF-1/2␣ and are highly conserved across species (Fig. 1A) . Unlike HIF-1/2␣, however, HIF-3␣1 lacks the C-TAD. Instead, it has a unique LZIP (leucine zipper) domain in the COOH-terminal region (Fig.  1A ). There is a bipartite nuclear localization signal in the NH 2 -terminal region (49) . HIF-3␣9 contains 669 aa, and it differs from HIF-3␣1 only by several amino acids in the very NH 2 -terminal end (38; Fig. 1B ). HIF-3␣9 can also be considered as full-length protein because it has all of the six characteristic domains (Fig. 1B) . HIF-3␣2 has 632 aa. Although it was once referred to as human inhibitory PAS (hIPAS), Maynard et al. (35) showed that its protein structure is different from that of mouse IPAS. HIF-3␣2 contains the bHLH, PAS-A and -B, PAC, ODD, and N-TAD domains but lacks the LIZP domain and the second LXXLL motif (35, Fig. 1B ). HIF-3␣3 and HIF-3␣5 were identified by searching cDNA entries in the GenBank database (35) but could not be detected by RT-PCR in multiple human fetal tissues and cell lines in a later study (38) . HIF-3␣3 lacks the bHLH and LZIP domains (35; Fig.  1B ). HIF-3␣4 is similar to the mouse IPAS in structure (Fig.  1B) . HIF-3␣4 has the bHLH, PAS-A, and PAS-B domain but lacks the ODD and LZIP domains (35) and functions as a dominant-negative form (36) . HIF-3␣5 only has the PAS-A, PAS-B, and PAC domains (35; Fig. 1B ). HIF-3␣6 was thought to be an artifact (38) . HIF-3␣7 lacks the bHLH domain. It also has a different sequence after the ODD/N-TAD domain due to the utilization of a unique exon 15 (38; Fig. 1B ). HIF-3␣8 lacks the bHLH domain only (38; Fig. 1B ). HIF-3␣10 retains intron 1. It has a premature in-frame stop codon leading to a 7 aa peptide if it is expressed (38) . Therefore, of the 10 reported human HIF-3␣ variants, 8 (HIF-3␣1, -3␣2, -3␣3, -3␣4, -3␣5, -3␣7, -3␣8, and -3␣9) may encode proteins. There are likely more human HIF-3␣ variants. According to NCBI and En- (10) . Three distinct mouse HIF-3␣ variants, i.e., the full-length HIF-3␣, IPAS, and neonatal and embryonic PAS (NEPAS), have been reported (10, 30, 52) . Although mouse HIF-3␣ is the first HIF-3 variant identified (10), it is listed as Hif3a-002 in the NCBI and Ensembl databases. NEPAS (52) is listed as Hif-3a-001, and IPAS is not listed in these databases. Mouse HIF-3␣ has 664 aa and is considered a full-length protein since it has all of the six characteristic domains (10; Fig. 1B ). Mouse IPAS was initially discovered as a negative regulator of hypoxia-inducible gene expression, and it was later found to be an alternative spliced transcript of the Hif-3␣ gene (30 -32) . The IPAS protein contains the bHLH, PAS-A, and PAS-B domains but lacks the ODD/N-TAD and LZIP domains (Fig. 1B) . NEPAS was discovered using RT-PCR assays designed to detect IPAS (52) . Mouse NEPAS has 664 aa. The first 8 aa are identical to those in IPAS but the rest of the protein is identical to HIF-3␣ (52) . It contains all of the six characteristic domains, i.e., bHLH, PAS-A, and PAS-B, PAC, ODD/N-TAD, and LZIP (Fig. 1B) . Searching the NCBI and Ensembl databases shows that there are two additional predicted transcripts, Hif3a-003 and Hif-3a-004. Hif-3a-004 may be a processing transcript, while Hif3a-003 is predicted to be a protein-coding variant.
HIF-3␣ in other vertebrate species. NCBI searching showed that the HIF-3␣ gene is present in all major groups of vertebrates, ranging from primates to birds, reptiles, and fish. The six-domain structure is well conserved. For example, zebrafish Hif-3␣1 has 626 amino acids and consists of the six characteristic domains (55; Fig. 1A ). Like its mammalian orthologs, zebrafish Hif-3␣1 lacks the C-TAD, and there is no conserved asparagine residue in the COOH-terminal region (55) . It is also evident that the HIF-3␣ gene is subjected to complicated posttranscriptional regulation in most, if not all, vertebrate species. For example, zebrafish Hif-3␣2 is an alternatively spliced variant (54) . This protein only has the N-TAD and LZIP domain (Fig. 1B) . Searching NCBI and Ensembl databases shows that the zebrafish hif-3␣ gene has two other predicted transcripts (55) .
Comparative studies suggested that invertebrates only have a single HIF␣ gene (8, 28) . Structural and functional analyses of the HIF␣ gene in amphioxus, a basal chordate that shares a common ancestor with the modern vertebrate lineage back to more than 520 million years ago, suggested that it resembles HIF-1/2␣ (5). Therefore, Hif-3␣ might have appeared later in evolution, likely after the emergence of vertebrates. In some teleost fish, the three Hif-3␣ genes may be duplicated due to the teleost specific whole-genome duplication (40) .
Spatial and Temporal Expression of HIF-3a Variants
Maynard et al. (35) used Northern blot analysis and detected the expression of 7.5-, 7.0-, 3.0-, and 1.5-kb HIF-3␣ transcripts in several human tissues with the highest levels seen in the heart, followed by placenta, lung, and skeletal muscle. The signal was barely detectable in the liver, brain, and kidney. Pasanen et al. (38) compared the mRNA expression of several human HIF-3␣ variants in the adult heart, brain, lung, liver, skeletal muscle, kidney, and pancreas by RT-PCR. HIF-3␣1 mRNA is abundantly expressed in the placenta but low in other tissues. HIF-3␣2 mRNA levels are expressed at a much lower level. HIF-3␣4 mRNA is highly expressed in these tissues except brain and spleen. HIF-3␣7 mRNA levels are high in these tissues except brain and kidney. HIF-3␣8 mRNA is detected in the pancreas but not other tissues. HIF-3␣9 mRNA levels are high in the heart and placenta but low in other tissues. HIF-3␣10 mRNA levels are lower than those of HIF-3␣1 in most of the adult tissues except heart. In the fetal stage, HIF-3␣10 mRNA levels are also lower than those of HIF-3␣1 in these tissues. These findings suggest that different HIF-3␣ variants are expressed in a tissue-and developmental stagespecific manner.
In the mouse model, Northern blot analysis detected a 7.5 kb HIF-3␣ transcript in adult thymus, lung, kidney, brain, and heart, but not in the liver, stomach, intestine, and muscle (10) . High levels of IPAS mRNA expression were detected by Northern blot analysis in the eye, while lower levels in cerebellum and cerebrum (30) . In situ hybridization detected strong IPAS mRNA signals in the epithelial cell layer of the retina (30) . In the cerebellum, IPAS mRNA expression was limited to the Purkinje cell layer (30) . Since Hif-3␣1, NEPAS, and IPAS mRNAs are alternatively spliced variants, Northern blot analysis and in situ hybridization cannot distinguish these variants. Yamashita et al. (52) used semiquantitative RT-PCR and found that the NEPAS mRNA is highly expressed in the embryonic heart, lung, brain, kidney, and liver at embryonic day (E) 15.5 and E17.5. Its expression in these tissues is decreased considerably at postnatal day (P) 15 and becomes barely detectable in the adult mouse tissues. In contrast, HIF-3␣ and IPAS mRNA were not detected in these embryonic tissues. At the adult stage, Hif-3␣ mRNA is detected in all of the above mentioned tissues (52) . Therefore, the levels of NEPAS, IPAS, and HIF-3␣ mRNA vary substantially in different tissues and at different developmental stages in mice.
The spatiotemporal expression pattern of Hif-3␣1 was also studied in zebrafish and other fishes (55, 40, 41, 25, 2) . During embryogenesis, Hif-3␣1 mRNA became detectable by RT-PCR as early as 4 h post fertilization (hpf). Its levels increased from 4 to 16 hpf and remained at relatively high levels thereafter. In situ hybridization analysis showed that Hif-3␣ mRNA was detectable in all embryonic tissues at the shield and epiboly stages but become enriched in the brain and retina after 24 hpf. In adult zebrafish, Hif-3␣1 mRNA was detected in all of the tissues examined with the highest levels in the ovary, followed by kidney, testis, and gills (55) .
Regulation of HIF-3␣ Expression and Activity
Oxygen-dependent degradation. HIF-1␣ and HIF-2␣ protein abundance and transcriptional activity are regulated by two hydroxylation events, prolyl hydroxylation in ODD by PHD and asparagine hydroxylation by FIH (39, 26) . Since HIF-3␣ lacks the C-TAD, the FIH-mediated hydroxylation mechanism is unlikely involved in HIF-3␣ regulation. Although it was reported that hypoxia treatment did not change HIF-3␣ protein stability in transfected COS-7 cells or Caki-1 cells (12, 46) , there is some evidence for an oxygen-dependent and PHD-VHL-mediated regulation of full-length HIF-3␣. All vertebrate full-length HIF-3␣ proteins have an ODD domain. Alignment human HIF-1/2/3␣ sequence shows that the ODD domain is highly conserved (35) . The LAPYIXMD motif, which is known to be critical for pVHL binding to HIF-1/2␣, is present in the human HIF-3␣ ODD domain (35) and in all known vertebrate HIF-3␣s (56). Maynard et al. (35) demonstrated that pVHL binds to human HIF-3␣1 and its ODD domain in vitro. This binding promotes HIF-3␣1 ubiquitylation and degradation in cultured human cells. Using rabbit reticulocyte lysate extracts containing enriched PHD and a HIF-3␣1-ODD P490A mutant, these authors showed that binding of pVHL to human HIF-3␣1 is increased by adding the extracts and is dependent on P490 (35). It is not clear whether or which of the three PHDs is actually involved in HIF-3␣ hydroxylation.
In vivo studies showed that zebrafish Hif-3␣1 degrades rapidly in zebrafish embryos and adult tissues under normoxia (55, 56) . Amino acid sequence alignment of major vertebrate HIF-1/2/3␣s suggests that there are several conserved proline and leucine residues that are analogous to those involved in human HIF-1␣ prolyl hydroxylation and pVHL binding (56) . These are P406, P492 (i.e., P490 in Ref. 35) , and L502 in human HIF-3␣1 protein, and P393, P493, and L503 in zebrafish Hif-3␣ (56) . The LAPYIXXXDFQL motif is also conserved in all of them. Mutation of P393 in zebrafish Hif-3␣1 had little effect on its abundance, while changing the P493 to alanine resulted in a significant increase in Hif-3␣ protein levels in vivo. The double P393A/P493A mutant behaved essentially the same as the P493A single mutant, suggesting that P493 is more critical for Hif-3␣ stability regulating (56) . pVHL recognizes human HIF-1␣ at L574, which is required for human HIF-1␣ instability (1) . When the corresponding residue in zebrafish Hif-3␣ (L503) is mutated together with P493 and P393, it resulted in a further increase in Hif-3␣ protein levels, suggesting that L503 contributes to the instability of zebrafish Hif-3␣1 under normoxia (56) . Mutation of P406, P492, and L502 in human HIF-3␣1 had similar effects in increasing its protein stability (56) . These data suggest that full-length HIF-3␣/Hif-3␣ is likely regulated by oxygen availability through the PHD-pVHL-mediated mechanism. It is possible that other ODD-containing HIF-3␣ variants may also be regulated in a similar fashion. Of note, the ODD domain is absent from several HIF-3␣ variants, including HIF-3␣4 and IPAS (35, 38) . These variants are unlikely to be regulated by PHD-VHL-mediated degradation.
Hypoxic induction of HIF-3␣ gene expression. In addition to altering protein stability, hypoxia also increases HIF-3␣ levels by inducing its gene transcription. This mechanism distinguishes the HIF-3␣ gene from the HIF-1␣ and HIF-2␣ genes and has been documented in human cells, mice, rats, and zebrafish (30 -32, 14, 1, 36, 27, 46, 55) . The hypoxic induction of HIF-3␣ gene expression may be particularly important for the HIF-3␣ variants lacking an ODD domain. Makino al. (30) reported that the IPAS mRNA expression was induced under hypoxia (30, 31) , while it decreased the mouse HIF-3␣ mRNA levels (31) . In a later study, it was found that hypoxia treatment also increased the HIF-3␣ mRNA levels in mice, albeit less robustly than IPAS mRNA levels (32) . Hypoxia induced IPAS mRNA transcription via a functional HRE in the mouse IPAS promoter and this upregulation was mediated by HIF-1␣ (32).
Heidbreder et al. (14) reported that hypoxia increases HIF-3␣ mRNA levels in rat cerebral cortex, hippocampus, and lung, whereas it does not affect the mRNA levels of HIF-1␣, HIF-2␣, and HIF-␤ mRNA expression in these tissues. Li et al. (27) found that hypoxia increased both human HIF-3␣ protein and mRNA levels in cultured human lung epithelial cells, and this is due to increased protein stability as well as transcriptional activation. Tanaka et al. (46) studied the hypoxic regulation of human HIF-3␣ expression in the Caki-1 renal carcinoma cells. Among the five variants examined, only HIF-3␣2 and HIF-3␣4 mRNAs are detected in these cells and their levels were increased in response to hypoxia treatment (46) . Knockdown of HIF-1␣, but not of HIF-2␣, significantly reduced the hypoxic induction of HIF-3␣2 and HIF-3␣4 mRNA. Chromatin immunoprecipitation (ChIP) assays and luciferase reporter assays showed that HIF-1 binds to a HRE in the human HIF-3␣ gene promoter region (46) . Immunohistochemistry analysis of human renal carcinoma sections revealed an overlap of HIF-1␣-positive and HIF-3␣-positive areas, suggesting that this HIF-1␣-mediated increase in HIF-3a gene expression may be functional in renal tumors in vivo (46) . A more recent study by Pasanen et al. (38) investigated the hypoxic regulation of the human HIF-3␣ and its variants by focusing on the three different transcriptional initiation sites. The exon 1a sequence is shared among HIF-3␣2, -3␣4, and 3␣ 9; the exon 1b sequence is present in HIF-3␣3, -3␣ 5, -3␣7, and -3␣8, while the exon 1c sequence is only found in HIF-3␣1 and -3␣10 (38) . The expression of all three of these alternative exons was significantly increased under hypoxia in Hep3B and Kelly cells, and the hypoxic induction was mediated by HIF-1␣ but not HIF-2␣ (38) .
Available data indicate that hypoxic induction of HIF-3␣ gene expression may be isoform and tissue-specific. For example, hypoxia did not increase HIF-3␣10 mRNA levels in HEK293, HepG3B, and Kelly cells, while it did increase the levels of HIF-3␣4 (38) . The expression of HIF-3␣7 mRNA was induced by hypoxia in HepG3B and Kelly cells but not in HEK293 cells (38) . In the case of HIF-3␣4, hypoxia increased its mRNA levels in Caki-1 renal carcinoma cells, while hypoxia treatment decreased HIF-3␣4 mRNA levels in HepG2 and HEK293A cells (36) . In vivo, hypoxia treatment results in an increase in HIF-3␣ mRNA levels in the adult rat cortex, hippocampus, lung, and heart but not in the liver (14) . Likewise, hypoxia significantly increases zebrafish Hif-3␣1 mRNA levels in the adult brain, heart, liver, and ovary but not in the kidney, gill, and testis (55) . The basal Hif-3␣1 mRNA levels in the gills and testis were comparable to those of the brain and heart. Although both kidney and ovary had relatively high levels of Hif-3␣1 mRNA levels under basal conditions, hypoxia only increased Hif-3␣1 mRNA levels in the ovary (55) . There is evidence that other factors may also be involved in the hypoxic induction of HIF-3␣ gene expression. An in vivo study in zebrafish embryos showed that overexpression of stabilized Hif-1␣ did not change Hif-3␣ mRNA levels, while it increased the expression of igfbp-1a mRNA, a known Hif-1 target gene (55) . It was reported that Hif-2␣ mediated hypoxiainduced Hif-3␣ gene expression in murine 3T3-L1 cells (13) . Augstein et al. (1) showed that human HIF-3␣2 mRNA expression in human umbilical venous endothelial cells (HUVECs) is induced by hypoxia and this hypoxic induction involves both HIF-1␣, HIF-2␣, and other factors. There is also evidence that several hypoxia-inducible miRNAs may mediate the hypoxia-induced HIF-3␣ gene expression (6).
Oxygen-independent regulation. Although HIFs are best known by their roles in the hypoxia response, these proteins are also subjected to a variety of oxygen-independent regulatory mechanisms. Inflammation, for example, is often associated with HIF-1/2 activation (39). Insulin-like growth factor (IGF)-I can stimulate HIF-1␣ expression via the PI3 kinase-mTOR signaling pathway (4, 50) , and transforming growth factor ␤1 increases HIF-1␣ expression and activity and induces mesenchymal-epithelial transition (MET) in renal tubular cells via oxygen-independent mechanisms (11). Likewise, NF-B directly modulates HIF-1␣ expression under normoxia (51) .
Recent studies suggest that HIF-3␣ expression is also under the regulation of several oxygen-independent mechanisms. Tumor necrosis factor-␣, a major mediator of inflammation, can increase IPAS mRNA expression in rat PC12 cells (8) . NF-B regulates human HIF-3␣2 mRNA expression in HUVECs (1). Treatments of rats with insulin (to induce hypoglycemia) or 2-deoxy-D-glucose (to induce cellular glucoprivation) resulted in a global increase in HIF-3␣ mRNA levels in many tissues. In comparison, HIF-1␣ mRNA levels were unaffected and HIF-2␣ mRNA and protein levels were increased only in the lung and heart after 2-deoxy-D-glucose treatment (15) . A recent study suggested that several unsaturated fatty acids including oleic acid and linoleic acid can bind to the PAS-B domain of HIF-3␣ in vitro (3), but the functional significance of the binding is not clear. An intriguing regulator of the Hif-3␣ gene is troponin I type 2 (TNNI2), which encodes a fast-twitch skeletal muscle protein (57) . ChIP assay showed that mouse TNNI2 protein binds to the HIF-3␣ promoter in primary osteoblasts. Moreover, a gain-of-function (K175del) TNNI2 mutant had a greater activity in transactivating the Hif-3␣ gene than the wild-type protein. Knock-in mice carrying the mutant Tnni showed increased HIF-3␣ expression in the long bone. The increased amount of HIF-3␣ was linked to impairment of angiogenesis, delay in endochondral ossification, and decrease in chondrocyte differentiation and osteoblast proliferation (57) .
Different Roles of HIF-3␣ Variants in the Transcriptional Response to Hypoxia
Until recently, it was generally thought that HIF-3␣ plays a negative role in the hypoxic induction of gene expression by inhibiting HIF-1/2␣ (53). This widely accepted view was derived mainly from overexpression studies of a subset of HIF-3␣ variants using artificial reporter constructs. Recent studies suggest that different HIF-3␣ variants play different or even opposite roles in regulating endogenous gene expression. In this section, I will group these HIF-3␣ variants in three categories for discussion.
Full-length HIF-3␣ proteins. Mouse HIF-3␣ was the first HIF-3␣ family member reported. When transfected and tested in COS-1 cells, mouse HIF-3␣ was able to dimerize with HIF-␤ (Arnt) and bind to HRE (10) . Interestingly, overexpression of HIF-3␣ alone did not increase the HRE-driven reporter plasmid expression in COS-1 cells. When coexpressed with HIF-␤, however, HIF-3␣ induced a strong increase in the HRE reporter plasmid expression. This activity was further enhanced by hypoxia and CoCl 2 treatment (10). Similar results were reported for mouse NEPAS (52) . Likewise, human HIF-3␣1 did not increase the expression of a HRE reporter plasmid when overexpressed in COS-7 cells alone, while it had significant activity when cotransfected with HIF-␤. When coexpressed with HIF-1␣ or HIF-2␣, HIF-3␣1 suppressed HIF-1␣-and HIF-2␣-induced HRE reporter activity (12) . These results led to the proposal that full-length HIF-3␣ has very weak transcriptional activity and it inhibits HIF-1␣ or HIF-2␣ action when HIF-␤ is limited, likely by competing for binding to the common HIF-␤ (Fig. 2B) .
A different picture emerged when the effect of HIF-3␣ in regulating the endogenous gene expression was investigated. IGF binding protein 1 (IGFBP-1) is a hypoxia-responsive gene in mammalian hepatocytes and zebrafish embryos (20 -23, 34, 42, 47) . Scharf et al. (42) showed that while overexpression of HIF-3␣ in rat primary hepatocytes increased IGFBP-1 mRNA levels, HIF-1␣ had no such effect. In human Hep3B cells, coexpression of HIF-3␣2, -3␣7, or -3␣8 with HIF-␤ increased the mRNA levels of several hypoxia-responsive genes such as EPO, GLUT1, and ANGPTL4 (16) . Transfection of siRNAs targeting HIF-3␣ variants decreased the mRNA levels of these genes (16) . These in vitro studies suggested that full-length HIF-3␣ and some of the long variants may function as transcriptional activators. Using a transgenic mouse model, Huang et al. (17) reported that overexpressing HIF-3␣ in the mouse pulmonary airway epithelial cells upregulated a number of genes known to be important for lung development, including Sox2, Rar␤, and Foxp2. Further experiments using ChIP assays and Sox2 promoter luciferase reporter plasmid indicated that HIF-3␣ binds to the promoter region of Sox2 and increases Sox2 transcription in cultured A549 cells under normoxia (17) . Using the zebrafish model, Zhang et al. (56) have provided several lines of in vivo evidence that the zebrafish Hif-3␣1 functions as an oxygen-regulated transcriptional activator. These include: 1) Hypoxia increased the HIF-3␣1 protein levels in zebrafish embryos and adult tissues. 2) Overexpression of a stabilized Hif-3␣1 increased the expression of several endogenous genes, including igfbp-1b, sqrdl, mclb, and zp3v2 in zebrafish embryos. 3) Hypoxia increased the expression of these genes, and dominant-negative inhibition or knockdown of Hif-3␣1 abolished or reduced the hypoxic induction. 4) ChIP-qPCR experiments showed that Hif-3␣ bound to specific region(s) in the target gene promoters and upregulated their expression. 5) Endogenous Hif-3␣ bound to these promoter regions under hypoxia but not normoxia. When Hif-3␣ was knocked down or inhibited, the Hif-3␣-DNA binding was reduced. 6) Human HIF-3␣1 and HIF-3␣9 overexpression and hypoxia treatment increased the expression of LC3C, REDD1, and SQRDL in human cells (56) . These results have provided strong evidence that HIF-3/Hif-3␣ mediates the transcriptional response to hypoxia and that this function is conserved evolutionarily ( Fig. 2A) .
There has been considerable progress in elucidating the HIF-3␣-regulated genes. Two transcriptomic studies have been reported. Huang et al. (17) generated a transgenic mouse line expressing Hif-3␣ in the lung epithelium. DNA microarray analysis of the lung RNA revealed that 30 genes had a more than 1.5-fold increase in the transgenic mice compared with their controls. Many of these upregulated genes are genes relevant to lung development. There were also 25 genes that were downregulated. It is unclear how many of these genes are direct Hif-3␣ target genes since wild-type HIF-3␣ protein was used and the RNA samples were collected from mice under normoxia. There were also notable changes in cellular composition in the transgenic mouse lung (17) . However, the authors provided evidence that at least one of them, Sox2, is a direct HIF-3␣ target gene when tested in cultured A549 cells (17) . Zhang et al. (56) performed transcriptomic studies in zebrafish embryos expressing a stabilized Hif-3␣ or Hif-1␣. While Hif-1␣ upregulated 690 genes (2-fold, P Ͻ 0.05), Hif-3␣ upregulated 155 genes. Ninety-seven genes overlapped in these two groups (Fig. 3A) . The Hif-3␣-regulated genes can be divided into three distinct groups: 1) genes that are upregulated by Hif-3␣ only, 2) genes that are regulated by both Hif-1␣ and Hif-3␣ with similar potencies, and 3) those that regulated by both Hif-1␣ and Hif-3␣ but with different potencies (56) . Bioinformatics analysis of these genes indicated that Hif-3␣ and Hif-1␣ expression regulates overlapping yet distinct biological processes and signaling pathways (Fig. 3, B and C) . For example, genes involved in glucose and amino acid metabolism, apoptosis, proteolysis, p53 signaling, and peroxisome proliferator-activated receptor (PPAR) signaling are enriched in both Hif-3␣-and Hif-1␣-expressing embryos. Hif-3␣, but not Hif-1␣, increases the expression of genes in the Jak-STAT signaling and NOD-like receptor signaling pathways. In comparison, genes involved in VEGF signaling, insulin signaling, MAPK signaling, and inositol phosphate metabolism are upregulated in Hif-1␣-expressing embryos only. Importantly, these genes are also upregulated by human HIF-3␣-1 and HIF-3␣ when tested in normal and cancerous human cells (56) .
Short HIF-3␣ variants. One of the well-studied Hif-3␣ variants is mouse IPAS. Mariko et al. (30) reported that overexpression of mouse IPAS in HeLa cells negatively regulated hypoxia-induced HRE-driven reporter plasmid activity and VEGF and PGK1 mRNA expression. When coexpressed with HIF-1␣, IPAS inhibited HIF-1␣ activity in a dose-dependent manner. Similar results were reported for human HIF-3␣4. Overexpression of HIF-3␣4 inhibited the HRE-driven reporter plasmid activity and hypoxia-induced GLUT1 and VEGF gene expression in cultured human cells (36) . siRNAmediated knockdown of HIF-3␣4 increased the expression of these hypoxia-responsive genes (36) . Using GST pull-down assays, Makino et al. (30) showed that IPAS formed a complex with HIF-1␣ that cannot bind to an HRE. IPAS did not dimerize with HIF-␤. They proposed that IPAS inhibits HIF-1 action by forming an abortive complex with HIF-1␣ (30) . Using coimmunoprecipitation assays, Maynard et al. (36) showed that HIF-3␣4 interacted with HIF-1␣ when transfected in HEK293 cells. Unlike IPAS, however, HIF-3␣4 also interacted with HIF-␤. While the HIF-3␣4/HIF-␤ complex did not appear to bind to an HRE, it inhibited the binding of the HIF-␣/␤ complex to the HRE in a dose-dependent fashion. A similar relationship between HIF-3␣4 and HIF-2␣ was reported (37) . These data suggest that mouse IPAS and human HIF-3␣4 act as dominant-negative inhibitors of HIF-1␣ and HIF-2␣ (Fig. 2C) . This mechanism may not be limited to the HIF-3␣ gene products in vertebrates. Searching NCBI and Ensembl databases suggests that the human HIF-1␣ gene may also have spliced variants that may lack ODD and C-TAD. The Drosophila HIF-␣ homolog gives rises to a full-length HIF␣ called Sima and a short spliced variant called svSima (7) . svSima lacks ODD and TAD. Like HIF-3␣4 and IPAS, expression of svSima inhibited Drosophila HIF (Sima/Tango)-stimulated reporter plasmid expression in a dose-dependent manner. Therefore, svSima acts as a dominant-negative inhibitor of HIF-␣ (7). Another interesting short variant is zebrafish Hif-3␣2 (54) . This isoform lacks a complete ODD domain and is insensitive to oxygen availability (Fig. 1B) . Although it does not have the bHLH, PAS, and PAC domains, it nevertheless has the ability to stimulate an HRE-driven reporter gene activity (Fig. 2D) . Whether this action requires Hif-␤ is unclear at present.
Other HIF-3␣ variants. Heikkila et al. (16) compared the activities of six HIF-3␣ variants. When they were transfected individually in CHO-K1 cells, HIF-3␣2, -3␣4, -3␣7, and -3␣8 alone had little activity in stimulating HRE-driven reporter gene expression, while the full-length HIF-3␣1 and -3␣9 had modest activity. Expression of each of these variants alone reduced hypoxia-induced HRE reporter plasmid expression and some hypoxia-responsive genes. When coexpressed with HIF-1␣ or HIF-2␣, all these human HIF-3␣ isoforms inhibited HIF-1␣ and HIF-2␣-induced HRE-driven reporter gene activity (16) . It was suggested that these long HIF-3␣ variants inhibit HIF-1␣ or HIF-2␣ action by competing for the common HIF␤ in cells with limited amounts of HIF␤ (Fig. 2B) . It is not clear whether these isoforms have any transcriptional activity.
In addition to the protein coding variants discussed above, searching NCBI and Ensembl databases suggested that there are other predicted transcripts. Five of them may be involved in nonsense-mediated mRNA decay. Nonsense-mediated mRNA decay is a mechanism that reduces errors in gene expression by eliminating mRNA transcripts that contain premature stop codons (29) . One of the predicted transcripts is a processed transcript, and seven others are retained intron sequence. Similar transcripts have been predicted in other primates. None of these predicted transcripts have been experimentally validated at present. Future studies will be needed to determine whether these transcripts are indeed expressed and what their functional roles may be.
Biological Function(s) of HIF-3␣ Variants
To date, the biological actions of several HIF-3␣/Hif-3␣ variants have been studied. Makino et al. (30) reported that hypoxia strongly induced IPAS mRNA expression in the mouse corneal epithelium and that delivery of an IPAS antisense oligonucleotide to mouse cornea reduced corneal neovascularization. Using xenograft assays, these authors showed that hepatoma cells overexpressing IPAS grew much slower than the control hepatoma cells in immunoincompetent SCID mice (30) . Maynard et al. (37) reported that VHL Ϫ / Ϫ CC-RCC cells overexpressing HIF-3␣4 grew much slower than the EGFP or nontransfected cells in SCID mice. These data suggest that IPAS/HIF-3␣4 negatively regulates tumor progression, likely by inhibiting HIF-1/2␣ activity. In cultured murine 3T3-L1 adipocytes, HIF-3␣ expression was induced during adipose differentiation and overexpression of HIF-3␣ at the early stage of differentiation accelerated 3T3-L1 adipocyte differentiation (13) . Yamashita et al. (52) disrupted the mouse Hif-3␣ locus using conventional gene knockout technology. The mutant mice exhibited enlarged right ventricle and pulmonary hyperplasia. The interpretation of the results is somewhat complicated because NEPAS, HIF-3␣1, and possibly IPAS were all affected in these mutant mice. The authors provided data suggesting that EPAS mRNA was highly expressed in mouse embryonic and postnatal hearts and lungs, while HIF-3␣ and IPAS mRNA was barely detectable in these embryonic and neonatal tissues. These data suggested that the observed phenotype probably reflects a NEPAS function. It was found that the mRNA levels of endothelin 1 and platelet-derived growth factor ␤, two known HIF-1/2␣ target genes, were increased in the mutant mouse lung endothelial cells, indicating that NEPAS may inhibit HIF-1/2␣ action. However, the mRNA levels of Vegf, another known HIF-1 target gene, were not changed in these mutant mice (52). Huang et al. (17) studied HIF-3␣ biological actions using a transgenic muse line expressing HIF-3␣ in the developing lung epithelium. They found that expression of Myc-Hif-3␣ resulted in aberrant alveolar formation and impaired post-pseudo glandular branching starting at E17.5. Histological analysis showed that expression of HIF-3␣ reduced the numbers of Clara cells, and type I and II aveolar cells. Gene expression analysis showed that expression of HIF-3␣ upregulated several proximal maker genes and downregulated genes expressed in distal lung epithelium (17) . These two studies indicate that HIF-3␣ and NEPAS are important for lung development and remodeling.
A more recent study addressed the role of Hif-3␣ in the hypoxic response in zebrafish embryos. Hypoxia causes growth and developmental retardation in zebrafish embryos (20, 22) . Knockdown of the endogenous Hif-3␣ partially alleviated the hypoxia-induced growth and developmental retardation, suggesting that Hif-3␣ plays a role in hypoxia-induced growth and developmental retardation (56) . Overexpression of wild-type Hif-3␣ resulted in a modest but statistically significant reduction in developmental speed and growth rate at 16 and 20 hpf but this effect disappeared at 24 hpf under normoxia. This was largely due to the rapid degradation of Hif-3␣ protein (56) . When a stabilized form of Hif-3␣ was expressed, it caused a much more profound and highly significant decrease in developmental speed and growth rate. Interestingly, overexpression of stabilized Hif-3␣ in zebrafish not only resulted in growth and developmental retardation, but also caused morphological abnormalities (56) . This is consistent with recent in vitro studies reporting that IPAS had proapoptotic activity and induced mitochondria depolarization and caspase-3 activation in rat PC12 cells (48) . IPAS acted in mitochondria by directly binding to Bcl-x(L) and other prosurvival proteins (48) .
Perspectives
HIF-3␣ biology is complex but several themes have emerged from recent studies. First, the HIF-3␣ gene encodes not one but rather many different proteins. These HIF-3␣ variants are expressed in different tissues, at different times, and are differentially regulated by hypoxia and other factors. Second, while some HIF-3␣ variants contain an ODD domain and are regulated by hypoxia at the protein stability level, others are regulated at the transcriptional level or both. The hypoxic induction of HIF-3␣ gene expression is mediated by HIF-1␣ and/or HIF-2␣ in a tissue-specific fashion. Third, different HIF-3␣ protein variants have different and even opposite functions. While the full-length HIF-3␣ protein functions as an oxygen-regulated transcription activator, HIF-3␣4/ IPAS acts as dominant -negative regulator of HIF-1/2␣. Some may have constitutive transcription activity. Other HIF-3␣ variants can inhibit HIF-1/2␣ actions by competing for the common HIF-␤. Finally, HIF-3 activates a transcriptional program that is not identical to that of HIF-1.
Despite the progress, important questions remain and there are many challenges ahead. To date, only a subset of the HIF-3␣ variants have been experimentally studied. It will be important to study the remaining variants. There is currently no unified nomenclature for various HIF-3␣ variants. For example, human HIF-3␣1 and HIF-3␣2 are listed as HIF3A-006 and HIF3A-003 in the NCBI and Ensembl databases. A unified nomenclature is clearly needed. Because the various HIF-3␣ variants are generated by the utilization of different promoters, different transcription initiation sites, and/or alternative splicing, it is not easy to measure individual variants. In fact, many published studies measured a mixture of several variants. To better understand HIF-3 biology, new strategies are needed to determine when, where, and at what levels these HIF-3␣ variants are expressed. The in vivo functions of various HIF-3␣ variants are still poorly understood. The conventional mouse gene knockout technology is not very useful in dissecting the functional roles of individual HIF-3␣ variants. The recently emerged CRISPR/Cas9 genome editing technology will be an effective approach to address this issue. Although it has become clear that the full-length HIF-3␣ activates a transcriptional program that is overlapping yet distinct from those regulated by HIF-1␣, it is still not clear why some genes are regulated by only HIF-3␣ or HIF-1␣, while others are regulated by both. More studies are needed to elucidate the molecular mechanisms determining the specificity of HIF-1, HIF-2, and HIF-3 in regulating target gene expression.
Last but not least, the existence of multiple variants is not unique to the HIF-3␣ gene or restricted to vertebrates. Human HIF-1␣ and HIF-2␣ genes can both give rise to multiple variants by alternatively splicing, alternative promoters, and alternative translation initiation codons. According to NCBI and Ensembl databases, there may be as many as 12 different human HIF-1␣ transcripts and 10 human HIF-2␣ transcripts. While some shorter HIF-1␣ proteins have been studied to some degree (see Ref. 39 for review), most of these HIF-1␣ and HIF-2␣ variants have not been explored. The fruit fly HIF-␣ gene produces a full-length HIF-␣ (Sima) and a short variant (svSima) (7) . The amphioxus HIF␣ gives rises to four alternatively spliced variants (5) . Future studies on these naturally occurring HIF-1/2/3␣ variants will provide unique insights into HIF biology and may lead to new therapeutic strategies to target HIFs.
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